SCHEMBL5799183

SCHEMBL5799183

Nc1ncc(-c2ncccc2C(F)(F)F)c(N2CCNCC2)n1

nearest known ligand 0.61

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 1/20 0.61
▸ HRH4 Q9H3N8 4/20 0.49
▸ CYP1A2 P05177 3/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ NCF1 P14598 1/20 0.43
▸ HRH3 Q9Y5N1 1/20 0.42
▸ PRKCA P17252 1/20 0.42
▸ FLT3 P36888 1/20 0.42
▸ GSK3B P49841 1/20 0.42
▸ PRKCQ Q04759 1/20 0.42
▸ CYP2C19 P33261 1/20 0.41
▸ TRPV1 Q8NER1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL233710 0.77 EPHX2 (1.00) EPHX2NCF1TRPV1
Hydrochloric Acid SCHEMBL10319192 0.76 EPHX2 (0.97) EPHX2NCF1TRPV1
Piperazine SCHEMBL5324447 0.76 EPHX2 (0.97) EPHX2NCF1TRPV1
SCHEMBL4560009 0.75 HRH4 (0.54) HRH4CYP1A2HRH3
SCHEMBL5800534 0.72 ADRB1 (0.58) EPHX2CYP1A2CYP2C9KDM4EALDH1A1
SCHEMBL5800527 0.72 CYP1A2 (0.72) EPHX2HRH4CYP1A2CYP2C9KDM4E
SCHEMBL5356587 0.72 EPHX2 (0.89) EPHX2NCF1TRPV1
Hydrochloric Acid SCHEMBL3321413 0.72 EPHX2 (0.64) EPHX2CYP1A2CYP2C9KDM4EALDH1A1
SCHEMBL3322414 0.70 EPHX2 (0.61) EPHX2HRH4CYP1A2CYP2C9KDM4E
SCHEMBL13724424 0.70 HRH3 (0.49) HRH4KDM4EALDH1A1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1644358-A2 BIARYL PIPERAZINYL-PYRIDINE ANALOGUES NEUROGEN CORPORATION (US) 2006-04-12 — — EP disclosed
WO-2005007648-A2 BIARYL PIPERAZINYL-PYRIDINE ANALOGUES NEUROGEN CORPORATION (US) 2005-01-27 — — WO disclosed
Send feedback